Abstract: Automatic token wallet generation includes generating a token wallet generated for a unique identifier that is associated with a person. The unique identifier may be a communication identifier like an email address, a telephone number, a social media handle, and so on. Storage space may be allocated for the token wallet and may be associated with the unique identifier. One or more NFTs (non-fungible tokens) may then be associated with the token wallet. In some examples, the token wallet may be automatically created in response to a request to associate an NFT with it. In other examples, the token wallet may be created in response to a request to perform other actions related to the token wallet.

Abstract: A non-fungible token (“NFT”) document platform includes a host platform that is operable to create and/or perform one or more transactions related to one or more NFTs on behalf of and/or for one or more other entities. Creation of the NFTs may involve creation of one or more smart contracts, storage of the smart contracts and/or the NFTs in one or more blockchains, and so on. The NFT document platform may also be operable to mint one or more documents, such as one or more birth certificates, contracts and other signed documents, titles, prescriptions, licenses and/or identification documents, checks, money, gift cards, and so on. The smart contracts and/or NFTs may correspond to the one or more minted documents. The NFTs may be usable to authenticate the minted documents, evidence ownership of the minted documents, control the ability to perform transactions regarding the minted documents, and so on.

Abstract: The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases.

Abstract: The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases.

Abstract: The present invention relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, intermediates thereto, and uses thereof. QS-7 is a potent immuno-adjuvant that is significantly less toxic than QS-21, a related saponin that is currently the favored adjuvant in anticancer and antiviral vaccines. Tedious isolation and purification protocols have hindered the clinical development of QS-7. A novel semi-synthetic method is provided wherein a hydrolyzed prosapogenin mixture is used to synthesize QS-7, QS-21, and related analogs, greatly facilitating access to QS-7 and QS-21 analogs for preclinical and clinical evaluation.

Abstract: A roof structure for an agricultural vehicle includes an upper roof assembly, a lower roof assembly, and an air-conditioning chamber formed in the lower roof assembly. The upper roof assembly is connectable to the lower roof assembly to surround the air-conditioning chamber. An inlet chamber and an outlet chamber for air-conditioned air are provided such that the inlet chamber and the outlet chamber between the lower roof assembly and the upper roof assembly include chambers separated from each other. The structure also includes a circulation opening for supplying recirculated air arranged at the inlet chamber and an air-guiding element arranged in the inlet chamber, at the circulation opening, and at the air-conditioning chamber. A region is sealed in relation to an external environment.

Abstract: The present invention relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, intermediates thereto, and uses thereof. QS-7 is a potent immuno-adjuvant that is significantly less toxic than QS-21, a related saponin that is currently the favored adjuvant in anticancer and antiviral vaccines. Tedious isolation and purification protocols have hindered the clinical development of QS-7. A novel semi-synthetic method is provided wherein a hydrolyzed prosapogenin mixture is used to synthesize QS-7, QS-21, and related analogs, greatly facilitating access to QS-7 and QS-21 analogs for preclinical and clinical evaluation.

Abstract: The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases and cancers.

Abstract: The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases and cancers.

Abstract: A roof structure for an agricultural vehicle includes an upper roof assembly, a lower roof assembly, and an air-conditioning chamber formed in the lower roof assembly. The upper roof assembly is connectable to the lower roof assembly to surround the air-conditioning chamber. An inlet chamber and an outlet chamber for air-conditioned air are provided such that the inlet chamber and the outlet chamber between the lower roof assembly and the upper roof assembly include chambers separated from each other. The structure also includes a circulation opening for supplying recirculated air arranged at the inlet chamber and an air-guiding element arranged in the inlet chamber, at the circulation opening, and at the air-conditioning chamber. A region is sealed in relation to an external environment.

Abstract: The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases.

Abstract: The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases.

Abstract: The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases.

Abstract: The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases.

Abstract: The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases and cancers.

Abstract: The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases.

Abstract: The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases.

Abstract: A roof structure for an agricultural vehicle includes an upper roof assembly, a lower roof assembly, and an air-conditioning chamber formed in the lower roof assembly. The upper roof assembly is connectable to the lower roof assembly to surround the air-conditioning chamber. An inlet chamber and an outlet chamber for air-conditioned air are provided such that the inlet chamber and the outlet chamber between the lower roof assembly and the upper roof assembly include chambers separated from each other. The structure also includes a circulation opening for supplying recirculated air arranged at the inlet chamber and an air-guiding element arranged in the inlet chamber, at the circulation opening, and at the air-conditioning chamber. A region is sealed in relation to an external environment.

Abstract: Systems and methods for processing financial transactions using smart chip technology are disclosed. The present invention provides for payments to be made to multiple payees with a single transaction performed via a single insertion or dip of a smart chip card into a smart chip terminal or a single tap of the smart chip card within a predetermined proximity of a smart chip terminal. Specific applications include transactions which include principal payment amounts paid to a first party with convenience fees and/or surcharges paid to a second party for the principal transaction.

Abstract: The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases.